Study Conduct

China: a quick and cost-efficient direction for drug development

Monday, April 25, 2011 12:12 PM

U.S. companies seeking to conduct clinical trials of new drugs and medical devices, Dr. R. Stephen Porter of Tennessee says China provides a lower-cost setting in which jobs can be accomplished more quickly, according to The Tennessean.

More... »

Streamlining IRB approval process yields dramatic results in turnaround time for University of Maryland

Monday, April 25, 2011 08:02 AM

Last March it took 35 days for a full Institutional Review Board (IRB) approval for a clinical trial from the University of Maryland’s School of Medicine, which reviews more than 1,000 applications annually. This March, IRB approval time dropped to 21 days, and just 13 days in February.

More... »

New data show number of principal investigators dropping 11% globally, and 20% in U.S.

Monday, April 25, 2011 08:02 AM

The number of principal investigators (P.I.s) filing 1572s worldwide has declined sharply, according to new data from the Tufts Center for the Study of Drug Development (CSDD).

More... »

Study: Preventive medicines require more true cost-effectiveness data

Thursday, April 21, 2011 12:12 PM

An analysis published in the British Medical Journal  claims clinical trials may not provide a reliable evidence base for the cost-effectiveness of preventive medicines, such as statins, in many medical practices, reported PharmaTimes.

More... »

Australian doctors discover disparities in cancer research

Tuesday, April 19, 2011 11:35 AM

Doctors in Australia, in a study conducted by the University of Sydney, revealed some serious disparities in cancer research.  The study indicates few clinical trials target four of the most serious types of cancer, according to a report in the Sydney Morning Herald.

More... »

Sanofi-aventis collaborates with Stanford University

Monday, April 18, 2011 12:49 PM

Sanofi-aventis has entered into a research collaboration agreement that will last several years through the Stanford University Bio-X program, according to Fierce Biotech.  The Stanford program supports, organizes, and facilitates interdisciplinary, collaborative and innovative research projects in the early phases of development.

More... »

Speculation flies over Logical Therapeutics as sites report non-payment for services

Monday, April 18, 2011 08:16 AM

Multiple investigative sites have been unable to collect payment from CRO PRA International for recent work they conducted on a phase IIb/III trial for Logical Therapeutics, a Waltham, Mass.-based biotechnology company developing a non-steroidal anti-inflammatory drug (NSAID), according to several independent sources.

More... »

Innovative paperless clinical trial study highlights time and cost savings

Friday, April 15, 2011 11:11 AM

Using interoperable digital identities, digital signatures and cloud computing can accelerate the initiation of a clinical trial and also lower costs, report a group of government and industry cancer researchers. They participated in the phase I of a pilot study that used interoperable digital identities and cloud-based digital signatures to eliminate reliance on paper forms in clinical trials.

More... »

BBK Worldwide to expand in E.U. and Latin America

Wednesday, April 13, 2011 12:15 PM

BBK Worldwide will expand in Europe and Latin America under the direction of Tatiana Sultzbach, who recently joined the patient recruitment firm in its market development department. 

More... »

Imperial acquisition of D. Anderson could signal consolidation trend in patient recruitment space

Monday, April 11, 2011 02:37 AM

Consolidation in the clinical trials industry is coming, many industry insiders say. It already has begun among drug sponsors and sporadically throughout the rest of the industry. But last week’s acquisition of D. Anderson & Co. by Imperial could mark the beginning of consolidation in the patient recruiting space.

More... »